Health5 days ago
Rocket Pharmaceuticals Withdraws FDA Application for Gene Therapy
Rocket Pharmaceuticals has voluntarily withdrawn its biologics marketing application for RP-L102, also known as mozafancogene autotemcel, from the U.S. Food and Drug Administration (FDA). This investigational...